NCT03129672

Brief Summary

The study show the clinical results of limb salvage for primary malignant bone tumor of the distal tibia using block excision of the tumor and reconstruction with allograft arthrodesis with different methods of fixation (plates or intramedullary nail system)

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2014

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

October 13, 2015

Completed
1.5 years until next milestone

First Posted

Study publicly available on registry

April 26, 2017

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2019

Completed
Last Updated

February 21, 2019

Status Verified

February 1, 2019

Enrollment Period

5 years

First QC Date

October 13, 2015

Last Update Submit

February 20, 2019

Conditions

Keywords

allograftdistal tibia sarcoma

Outcome Measures

Primary Outcomes (1)

  • principal diagnosis of the patients that wen trough ankle after resection of a primary malignant tumor of the distal tibia

    osteosarcoma: 5 patientas (2 females of 18 and 15 years old and 3 males of 19, 24 and 16 years old) telangiectasic osteosarcoma (1 female of 21 years old) Ewing sarcoma (1 male of 33 years old)

    1 month

Secondary Outcomes (3)

  • mobility

    5 month to 10 years follow up

  • mortality

    5 months to 10 years follow up

  • MSTS SCORE

    5 month to 10 years follow up

Interventions

patients that underwent trought a block resection of a malignant tumor of the distal tibia and reconstruction with allograft arthrodesis

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

all patients that were diagnosis with primary malignant bone tumor of the distal tibia and went trough resection and reconstruction with allograft

You may qualify if:

  • \- all patients with histopathologyc diagnosis of a primary malignant bone tumor at the distal tibia that went through a tumor resection and received reconstruction with allograft as first surgical treatment

You may not qualify if:

  • none histopatologic proved diagnosis
  • patients that received other kind of surgical treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Panama Children Hospital

Panama City, 0823, Panama

RECRUITING

Related Publications (9)

  • Burrows HJ, Wilson JN, Scales JT. Excision of tumours of humerus and femur, with restoration by internal prostheses. J Bone Joint Surg Br. 1975 May;57(2):148-59.

    PMID: 1141281BACKGROUND
  • Ebeid W, Amin S, Abdelmegid A, Refaat Y, Ghoneimy A. Reconstruction of distal tibial defects following resection of malignant tumours by pedicled vascularised fibular grafts. Acta Orthop Belg. 2007 Jun;73(3):354-9.

    PMID: 17715726BACKGROUND
  • Liu T, Guo X, Zhang X, Li Z, Zhang Q. Reconstruction with pasteurized autograft for primary malignant bone tumor of distal tibia. Bull Cancer. 2012 Sep;99(9):87-91. doi: 10.1684/bdc.2012.1626.

    PMID: 22863837BACKGROUND
  • Ruggieri P, Angelini A, Jorge FD, Maraldi M, Giannini S. Review of foot tumors seen in a university tumor institute. J Foot Ankle Surg. 2014 May-Jun;53(3):282-5. doi: 10.1053/j.jfas.2014.01.015.

    PMID: 24751209BACKGROUND
  • Azevedo CP, Casanova JM, Guerra MG, Santos AL, Portela MI, Tavares PF. Tumors of the foot and ankle: a single-institution experience. J Foot Ankle Surg. 2013 Mar-Apr;52(2):147-52. doi: 10.1053/j.jfas.2012.12.004. Epub 2013 Jan 16.

    PMID: 23333280BACKGROUND
  • Zeytoonjian T, Mankin HJ, Gebhardt MC, Hornicek FJ. Distal lower extremity sarcomas: frequency of occurrence and patient survival rate. Foot Ankle Int. 2004 May;25(5):325-30. doi: 10.1177/107110070402500509.

    PMID: 15134614BACKGROUND
  • Clayer M, Doyle S, Sangha N, Grimer R. The toronto extremity salvage score in unoperated controls: an age, gender, and country comparison. Sarcoma. 2012;2012:717213. doi: 10.1155/2012/717213. Epub 2012 Sep 13.

    PMID: 23028240BACKGROUND
  • Ozger H, Eralp L, Turker M, Basaran M. Surgical treatment of malignant tumors of the foot and ankle. Int J Clin Oncol. 2005 Apr;10(2):127-32. doi: 10.1007/s10147-004-0470-9.

    PMID: 15864699BACKGROUND
  • Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993 Jan;(286):241-6.

    PMID: 8425352BACKGROUND

MeSH Terms

Conditions

Bone Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBone DiseasesMusculoskeletal Diseases

Study Officials

  • patricia bonilla, MD

    Hospital del Niño

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Orthopedic Oncologist MD

Study Record Dates

First Submitted

October 13, 2015

First Posted

April 26, 2017

Study Start

May 20, 2014

Primary Completion

June 1, 2019

Study Completion

August 31, 2019

Last Updated

February 21, 2019

Record last verified: 2019-02

Locations